Survey of the effect of gabapentin on post-operative pain of shoulder rotator cuff surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100127003213N9

Enrollment

Registered

2020-05-19

Start date

2020-06-09

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder rotator cuff surgery. Rotator cuff tear or rupture, not specified as traumatic

Interventions

Intervention 1: Intervention group: Patients in group G will receive 300 mg of gabapentin at 6 pm on the first day after surgery and 600 mg of gabapentin in divided doses at 6 am and 6 pm on the secon

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients undergoing shoulder rotator cuff surgery Age 30-65 years old (ASA) I-II

Exclusion criteria

Exclusion criteria: Sensitivity to gabapentin History of hypertension Heart disease Liver and kidney disease Acute or chronic pain associated with other areas of the body Any dependence on narcotics and psychotropic drugs Continuous use of tranquilizers for depression and anxiety disorders and seizure disorders

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: The severity of pain is measured by Numeric Rating Scale , every 2 hours to 6 hours, and then every 6 hours to 24 hours. Method of measurement: Numeric Rating Scale (NRS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamira Safari

Shiraz University of Medical Sciences

Safari.anest@gmail.com+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026